In this week’s issue:
- Children’s Heart Foundation – Congenital Heart Disease Research (reminder)
- Lung Cancer Research Foundation – Research Grants (reminder)
- Canadian Epigenetics, Environment and Health Research Consortium Network – Travel Awards
Awards and Honours:
- Sanofi – Institut Pasteur 2016 Awards (reminder)
- UBC Centre for Blood Research Seminar Series – Dr. Catherine Tenn: An Experimental Model of Hemorrhagic Shock
- Faculty of Medicine – Public Lecture by Professor Sir John Tooke: Realising the societal benefit of modern medical science: The role of contemporary academic health service alliances
Deadline: June 3, 2016
The Children’s Heart Foundation is accepting proposals from investigators for clinical research projects related to identifying the cause and improving methods for diagnosing, treating, and preventing congenital heart defects.
Grants of up to $100,000 per year for a maximum of two years will be awarded for new research in the areas of molecular genetics/biochemistry, devices/procedural research (catheterization and surgical), and long-term care of children with congenital heart defects.
To be eligible, investigators must be affiliated with an educational institution or nonprofit organization considered tax exempt under Section 501(c)(3) of the Internal Revenue Code.
For complete program guidelines and application instructions, please visit the Children’s Heart Foundation website.
Deadline: July 1, 2016
The Lung Cancer Research Foundation’s grant program provides funding for innovative research focused on the prevention, diagnosis, treatment and cure of lung cancer. The Foundation encourages applications for projects investigating a wide variety of research topics, including:
- Prevention and screening for early detection
- Identification of new biomarkers and the development of targeted therapies
- The development of next-generation chemotherapeutic agents
- Supportive measures for people with lung cancer and their families
- Quality of care and outcomes research
The maximum award amount is $150,000 for a period of two years (disbursed at $75,000 per year).
For further information, please visit the LCRF website.
Deadline: See below
Funding is available to assist graduate students, postdoctoral fellows, and medical students at eligible Canadian institutions with the cost of travel to present abstracts at national and international epigenetics meetings.
- Canadian Conference on Epigenetics/CEEHRC annual meeting (September 18-21 2016, Estérel, QC): each award will cover the cost of registration (including shared room and meals), plus reimbursement of economy class travel costs up to $500. Applications must be submitted by July 7th 2016. Decisions will be made by July 24th 2016.
- IHEC annual meeting (September 7-9 2016, Brussels, Belgium): each award will cover the cost of registration plus reimbursement of economy class travel / accommodation costs up to $1,000. Applications must be submitted by July 7th 2016. Decisions will be made by July 24th 2016.
- All other meetings: $500 per award for Canadian meetings; $1,000 per award for international meetings. Please submit application at least 6 weeks prior to the conference start date. Decisions will be made within 3 weeks.
Knowledge Dissemination Experts
As part of CEEHRC’s outreach mandate, funding is available to allow knowledge dissemination professionals to attend the network’s annual meeting. Our definition of knowledge dissemination professionals includes, but is not limited to, journalists (traditional and new media); educators; and representatives of patient groups, charitable foundations, and similar organizations.
As a condition of funding, the awardees will communicate the contents of the meeting to their target audiences. All dissemination products must be made available in English and/or French (in addition to other languages, as appropriate to the intended audience), and must target Canadian or global audiences. Priority will be given to qualified Canadian applicants.
Each award will cover the cost of meeting registration (which includes all accommodation and meals), plus reimbursement of economy class travel costs up to $1,000. Applications must be submitted by July 7th 2016. Decisions will be made by July 24th.
For further information, and to download the application form, please visit the CEEHRC website.
AWARDS AND HONOURS:
Nomination Deadline: June 14, 2016
Sanofi and the Institut Pasteur are pleased to announce the Sanofi – Institut Pasteur 2016 Awards.
These Awards will honor four scientists, whose outstanding research in the life sciences is contributing to progress in global public health, specifically in the following fields:
- Drug Resistance
- Tropical and Neglected Diseases
There will be three categories of awards:
- One International Senior award (€ 150 000)
- One International Mid-career award (€ 100 000)
- Two National Junior awards (€ 75 000 each)
The deadline to submit nominations is Tuesday, 14th June, 2016.
For further information, please visit the Sanofi website.
UBC Centre for Blood Research Seminar Series – Dr. Catherine Tenn: An Experimental Model of Hemorrhagic Shock
Date & Time: May 18, 2016; 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. Catherine Tenn
Casualty Management Section, Defence Research and Development Canada, Suffield Research Centre
Hemorrhage continues to be the leading cause of potentially survivable death on the battlefield. For decades, extensive efforts have been made to elucidate the pathophysiological mechanisms and the immunologic changes associated with severe bleeding. Most of what we know about hemorrhagic shock comes from the results of pre-clinical studies with animal models. However, translating these experimental findings into clinical application is challenging and there is still a need for better understanding of the animal models being used. There are advantages and disadvantages associated with the different models of hemorrhage. Taking these issues into consideration, a reproducible and standardized experimental model of hemorrhagic shock was developed in collaboration between University of Calgary and Defence Research and Development Canada, Suffield Research Centre. The model will be used to assess a number of emerging treatment strategies for hemorrhage and hemorrhagic shock to reduce trauma-related mortality which is a topic of great interest to both civilian and military medical communities.
Date & Time: June 8, 2016; 5-6:30pm
Location: Room 2263, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel Street, Vancouver
Sir John Tooke
VP Health, University College London
Professor Sir John Tooke, Executive Chairman and Founder of Academic Health Solutions, has 20 years’ experience of developing and leading successful academic health alliances. A clinician scientist with interests in diabetes and vascular medicine, John led from inception the Peninsula Medical School, the first new Medical School in the UK for 40 years which graduated its first students in 2007. For the last six years he led the School of Life and Medical Sciences at UCL, London, as Vice Provost (Health) and Academic Director of UCL Partners, an academic health science system that subserves a population of 6 million. He is the immediate Past President of the Academy of Medical Sciences in the UK and previously Chair of the UK’s Medical School Council. He is currently co-Chair of the Centre for the Advancement of Sustainable Medical Innovation, a joint institute between Oxford University and UCL.